In addition, it was also found that PAX2 transcriptional factor can bind to the promoter of previously reported transmembrane-domain family TM4SF1, a gene that played a role in gemcitabine resistant pancreatic cancer [83]. This evidence concerns the gene PAX2 and familial pancreatic carcinoma.